Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Orena · SciRah

Researcher profile · Semantic Scholar

B. Orena

Share profile

B. Orena — researcher profile on SciRah

h-index: 13
Works: 31
Citations: 488

Most-cited papers

Shifts of Faecal Microbiota During Sporadic Colorectal Carcinogenesis
G. Mori, S. Rampelli, B. Orena, C. Rengucci +10 more
2018Scientific Reports76 citations Open access
Semantic Scholar
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity
Paulo F. M. Oliveira, Brigitte Guidetti, A. Chamayou, C. André-Barrès +11 more
2017Molecules76 citations Open access
Semantic Scholar
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK
L. Chiarelli, G. Mori, B. Orena, M. Esposito +19 more
2018Scientific Reports42 citations Open access
Semantic Scholar
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
T. Matviiuk, Jan Madacki, G. Mori, B. Orena +10 more
2016European journal of medicinal chemistry40 citations
Semantic Scholar
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
M. Esposito, Sára Szádocka, Giulia Degiacomi, B. Orena +15 more
2017ACS Infectious Diseases38 citations Open access
Semantic Scholar
Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients
G. Mori, B. Orena, Ilenia Cultrera, Giulia Barbieri +5 more
2019Frontiers in Microbiology33 citations Open access
Semantic Scholar
New and Old Hot Drug Targets in Tuberculosis.
L. Chiarelli, G. Mori, M. Esposito, B. Orena +1 more
2016Current Medicinal Chemistry30 citations
Semantic Scholar
Time Length of Negativization and Cycle Threshold Values in 182 Healthcare Workers with Covid-19 in Milan, Italy: An Observational Cohort Study
L. Cariani, B. Orena, F. Ambrogi, S. Gambazza +10 more
2020International Journal of Environmental Research and Public Health27 citations Open access
Semantic Scholar
Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
Elda Meta, C. Brullo, M. Tonelli, S. Franzblau +6 more
2019Medicinal chemistry24 citations
Semantic Scholar
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity
Damien Veau, S. Krykun, G. Mori, B. Orena +6 more
2016ChemMedChem19 citations
Semantic Scholar
Synthesis, oxidation potential and anti–mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism
J. Laborde, Céline Deraeve, L. Lecoq, A. Sournia-Saquet +5 more
201618 citations
Semantic Scholar
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053.
L. Chiarelli, E. Salina, G. Mori, T. Azhikina +17 more
2019ACS Infectious Diseases17 citations Open access
Semantic Scholar
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
G. Mori, B. Orena, Clara Franch, L. Mitchenall +25 more
2018Tuberculosis14 citations
Semantic Scholar
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
Dennis Mujuni, Dianah Linda Kasemire, Ivan Ibanda, Joel Kabugo +12 more
2022BMC Infectious Diseases13 citations Open access
Semantic Scholar
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
G. Mori, B. Orena, L. Chiarelli, Giulia Degiacomi +5 more
2020Frontiers in Microbiology7 citations Open access
Semantic Scholar
Evaluation of heteroatom-rich derivatives as antitubercular agents with InhA inhibition properties
Bachar Rébat Moulkrere, B. Orena, G. Mori, N. Saffon-Merceron +6 more
2017Medicinal Chemistry Research7 citations
Semantic Scholar
Synthesis, Oxidation Potential and anti‐Mycobacterial Activity of Isoniazid and Analogues: Insights into the Molecular Isoniazid Activation Mechanism.
J. Laborde, Céline Deraeve, L. Lecoq, A. Sournia-Saquet +5 more
20164 citations
Semantic Scholar
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
G. Alicandro, V. Daccò, L. Cariani, M. Contarini +8 more
2021Journal of Cystic Fibrosis3 citations Open access
Semantic Scholar
Synthesis and evaluation of β-hydroxytriazoles and related compounds as antitubercular agents
C. Menendez, G. Mori, M. Maillot, Isabelle Fabing +6 more
20151 citations Open access
Semantic Scholar
P220 The impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on airway infections in people with cystic fibrosis (pwCF)
B. Orena, D. Girelli, M. F. Liporace, M. Tonelli +6 more
2025Journal of Cystic Fibrosis0 citations
Semantic Scholar
P198 Phenotypic and genotypic characterization of Mycobacterium abscessus complex in cystic fibrosis patients
M. F. Liporace, A. Teri, D. Girelli, B. Orena +8 more
2024Journal of Cystic Fibrosis0 citations Open access
Semantic Scholar
Unravelling the pathogenicity of Mycobacterium abscessus cystic fibrosis clinical isolates in respiratory infection models
F. Saliu, F. di Marco, Francesca Nicola, A. Spitaleri +7 more
2023Tuberculosis and non-tuberculous mycobacterial diseases0 citations
Semantic Scholar
Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross-sectional study
Dennis Mujuni, W. Ssengooba, Ivan Ibanda, Joel Kabugo +17 more
2023F1000Research0 citations Open access
Semantic Scholar
P155 The impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on occurrence of bacterial lung infections in cystic fibrosis patients
L. Cariani, G. Alicandro, A. Teri, D. Girelli +6 more
2023Journal of Cystic Fibrosis0 citations
Semantic Scholar
532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
V. Daccò, L. Cariani, G. Alicandro, C. Rosazza +5 more
2022Journal of Cystic Fibrosis0 citations Open access
Semantic Scholar
ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
G. Alicandro, V. Daccò, L. Cariani, M. Contarini +5 more
2022Journal of Cystic Fibrosis0 citations Open access
Semantic Scholar
New antitubercular prodrugs with novel mechanisms of action
B. Orena
20180 citations
Semantic Scholar
In search for the active metabolites and the cellular target of the antitubercular prodrug TP053
L. Chiarelli, B. Orena, G. Mori, Makarov +9 more
20170 citations
Semantic Scholar
CTP synthetase and panthotenate kinase: two new tools for a multi-targeting strategy against Mycobacterium tuberculosis
L. Chiarelli, M. Esposito, B. Orena, G. Mori +8 more
20170 citations
Semantic Scholar
Evaluation of heteroatom-rich derivatives as antitubercular agents with InhA inhibition properties
Bachar Rébat Moulkrere, B. Orena, G. Mori, N. Saffon-Merceron +6 more
2017Medicinal Chemistry Research0 citations
Semantic Scholar
Study of the intestinal microbiome in the progression of sporadic colorectal adenoma-carcinoma sequence
G. Mori, B. Orena, F. Armanini, N. Segata +10 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Mori×19
Invite
G. Mori — researcher profile on SciRah
M. Pasca×16
Invite
M. Pasca — researcher profile on SciRah
L. Chiarelli×8
Invite
L. Chiarelli — researcher profile on SciRah
C. Lherbet×6
Invite
C. Lherbet — researcher profile on SciRah

×6

Invite

G. Riccardi — researcher profile on SciRah

Invite

L. Cariani — researcher profile on SciRah

Invite

V. Daccò — researcher profile on SciRah

J. Korduláková×4

Invite

J. Korduláková — researcher profile on SciRah

Invite

M. Baltas — researcher profile on SciRah

Invite

M. Esposito — researcher profile on SciRah

Giulia Degiacomi×4

Invite

Giulia Degiacomi — researcher profile on SciRah

Invite

M. Manfredi — researcher profile on SciRah